Apaza César Jeri, Días Marisol, García Tejedor Aurora, Boscá Lisardo, Laparra Llopis José Moisés
Molecular Immunonutrition Group, Madrid Institute for Advanced Studies in Food (IMDEA Food), Ctra Cantoblanco, 8, 28049 Madrid, Spain.
Center of Biological Enginneering (CEB), Iberian Nantotechnology Laboratory (INL), University of Minho, 4715-330 Braga, Portugal.
Biomedicines. 2024 Feb 1;12(2):341. doi: 10.3390/biomedicines12020341.
Nucleotide-binding oligomerization domain-like (NOD) receptors rely on the interface between immunity and metabolism. Dietary factors constitute critical players in the activation of innate immunity and modulation of the gut microbiota. The latter have been involved in worsening or improving the control and promotion of diseases such as obesity, type 2 diabetes, metabolic syndrome, diseases known as non-communicable metabolic diseases (NCDs), and the risk of developing cancer. Intracellular NODs play key coordinated actions with innate immune 'Toll-like' receptors leading to a diverse array of gene expressions that initiate inflammatory and immune responses. There has been an improvement in the understanding of the molecular and genetic implications of these receptors in, among others, such aspects as resting energy expenditure, insulin resistance, and cell proliferation. Genetic factors and polymorphisms of the receptors are determinants of the risk and severity of NCDs and cancer, and it is conceivable that dietary factors may have significant differential consequences depending on them. Host factors are difficult to influence, while environmental factors are predominant and approachable with a preventive and/or therapeutic intention in obesity, T2D, and cancer. However, beyond the recognition of the activation of NODs by peptidoglycan as its prototypical agonist, the underlying molecular response(s) and its consequences on these diseases remain ill-defined. Metabolic (re)programming is a hallmark of NCDs and cancer in which nutritional strategies might play a key role in preventing the unprecedented expansion of these diseases. A better understanding of the participation and effects of immunonutritional dietary ingredients can boost integrative knowledge fostering interdisciplinary science between nutritional precision and personalized medicine against cancer. This review summarizes the current evidence concerning the relationship(s) and consequences of NODs on immune and metabolic health.
核苷酸结合寡聚化结构域样(NOD)受体依赖于免疫与代谢之间的界面。饮食因素是先天免疫激活和肠道微生物群调节的关键因素。后者与肥胖、2型糖尿病、代谢综合征等非传染性代谢疾病(NCDs)的病情恶化或改善以及癌症发生风险有关。细胞内NOD与先天免疫“Toll样”受体发挥关键的协同作用,导致引发炎症和免疫反应的多种基因表达。人们对这些受体在静息能量消耗、胰岛素抵抗和细胞增殖等方面的分子和遗传影响的理解有了进步。受体的遗传因素和多态性是NCDs和癌症风险及严重程度的决定因素,可以想象饮食因素可能会因其而产生显著不同的后果。宿主因素难以影响,而环境因素在肥胖、2型糖尿病和癌症中占主导地位,并且可以通过预防和/或治疗的目的来加以应对。然而,除了认识到肽聚糖作为其典型激动剂激活NODs之外,其潜在的分子反应及其对这些疾病的影响仍不明确。代谢(重新)编程是NCDs和癌症的一个标志,营养策略可能在预防这些疾病的空前蔓延中发挥关键作用。更好地理解免疫营养膳食成分的参与和作用可以促进综合知识,推动营养精准与个性化抗癌医学之间的跨学科科学发展。本综述总结了目前关于NODs与免疫和代谢健康之间关系及后果的证据。